Pure Extracts Technologies - CEO, Ben Nikolaevsky.
CEO, Ben Nikolaevsky.
Source: Twitter.
  • Pure Extracts (PULL) has signed a cannabis supplier agreement with Shoppers Drug Mart
  • The initial purchase order includes six SKUs
  • The company views the agreement as a meaningful revenue generator into the future
  • Pure Extracts Technologies is a cannabis and psychedelics company focused on extraction and production
  • Pure Extracts (PULL) is up by 20 per cent trading at $0.03 per share

Pure Extracts (PULL) has signed a cannabis supplier agreement with Shoppers Drug Mart.

Subsidiary Pure Extracts Manufacturing will supply Shoppers with an initial purchase order of six SKUs. These include Pure Pulls THC and CBD full spectrum oil vape cartridges and Pure Chews THC and CBD edible gummies.

The products will be available on the Medical Cannabis by Shoppers platform.

The news follows an order from the Ontario Cannabis Store earlier this week.

“We are excited about joining such a trusted health and wellness retailer as Shoppers and look forward to introducing our brands to their medical customers,” stated Pure Extracts’ CEO, Ben Nikolaevsky.

“This marks another successful milestone in the expansion of our line of branded products and we believe this distribution relationship will contribute a significant amount of revenue to our financials over time,” he added.

Pure Extracts Technologies is a cannabis and psychedelics company focused on extraction and production.

Pure Extracts (PULL) is up by 20 per cent trading at $0.03 per share as of 9:37 am EST.

More From The Market Online

The Market Online’s Weekly Cannabis Report – April 19, 2024

Cannabis news this week: Canopy Growth shareholders overwhelmingly voted to approve a new class of exchangeable shares.

Buzz on the Bullboards: Challenges amid inflation and geopolitical tensions

Canadian and U.S. stock markets grapple with a host of challenges, from surging inflation data to escalating tensions in the Middle East.

Xebra Brands receives second CBD approval by Mexican authority

Xebra Brands (CSE:XBRA) announces it has received its second COFEPRIS approval for CBD product authorization in Mexico.
Canopy Growth - CEO, David Klein.

Canopy Growth shareholders approve Canopy USA asset strategy

After rearranging its capital structure, Canopy Growth (TSX:WEED) will be closer to establishing a U.S.-based multi-state operator.